Login to Your Account

Washington Roundup

Friday, October 26, 2012
The FDA published fee notices by the Generic Drug User Fee Amendments of 2012, establishing fee amounts and due dates for applications pending on Oct. 1, which are considered backlog applications, and for new generic drug submissions received as of Oct. 1.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription